Spots Global Cancer Trial Database for A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors
Official Title: A Phase 1，Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ascendind Doses of BPI-28592 in Subjects With Advanced Solid Tumors
Study ID: NCT05302843
Conditions
Interventions
Study Description
Brief Summary: This is an open-labe Phase I study of BPI-28592 for the treatment of patients with solid tumors
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine, HangZhou, Zhejiang, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
